The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease

Pankaj Puar; Shamon Ahmed; Makoto Hibino; Aryan Pasricha; Arjun Pandey; Amaan Bari; Raj Verma; Adrian Quan; Andrew T Yan; Kim A Connelly; Hwee Teoh; C David Mazer; Subodh Verma

doi:10.1111/dom.15119

The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease

Diabetes Obes Metab. 2023 Sep;25(9):2765-2769. doi: 10.1111/dom.15119. Epub 2023 May 29.

Authors

Pankaj Puar^{1

2

3}, Shamon Ahmed³, Makoto Hibino⁴, Aryan Pasricha⁵, Arjun Pandey⁶, Amaan Bari¹, Raj Verma⁷, Adrian Quan^{1

2}, Andrew T Yan^{2

8

9}, Kim A Connelly^{2

8

9

10}, Hwee Teoh^{1

2

11}, C David Mazer^{2

10

12

13

14}, Subodh Verma^{1

2

14

15}

Affiliations

¹ Division of Cardiac Surgery, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
² Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada.
³ Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
⁴ Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
⁵ Wake Forest University, Winston-Salem, North Carolina, United States.
⁶ Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁷ School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁸ Division of Cardiology, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
⁹ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
¹⁰ Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
¹¹ Division of Endocrinology and Metabolism, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
¹² Department of Anaesthesia, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
¹³ Department of Anaesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.
¹⁴ Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
¹⁵ Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

PMID: 37246798
DOI: 10.1111/dom.15119

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Benzhydryl Compounds / therapeutic use
Coronary Artery Disease* / complications
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Glucosides
Humans
Obesity / complications
Obesity / drug therapy

Substances

Benzhydryl Compounds
empagliflozin
Glucosides

Associated data

ClinicalTrials.gov/NCT02998970